FDA Inspection
Janaki (NMI) Nadarajah DPMJanaki (NMI) Nadarajah DPM – FDA Inspection, Feb 4, 2016
Record Details
This FDA Inspection record concerns Janaki (NMI) Nadarajah DPM, with an inspection on February 4, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Janaki (NMI) Nadarajah DPM
- Inspection Date
- February 4, 2016
- Product Type
- Biologics
View Company Profile
ID · a3a986db-1476-4f42-b7bd-2e79467d4a45
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 962330
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Janaki (NMI) Nadarajah DPM
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2024 | Not classified | Atlanta District Office | Bioresearch Monitoring |
Other documents for Janaki (NMI) Nadarajah DPM
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.